VERACYTE, INC. VCYT
VERACYTE, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $517.1M | $445.8M | $361.1M | $296.5M | $219.5M | $117.5M | $120.4M | $92.0M | $72.0M | $65.1M |
| Gross profit | $362.5M | $298.1M | $229.7M | $175.7M | — | — | — | — | — | — |
| R&D expense | $70.8M | $69.3M | $57.3M | $40.6M | $29.8M | $17.2M | $14.9M | $14.8M | $13.9M | $15.3M |
| Operating income | $57.8M | $16.1M | -$85.8M | -$41.1M | -$81.9M | -$35.4M | -$15.1M | -$22.2M | -$26.5M | -$28.8M |
| Interest expense | — | — | — | — | — | $229,000 | $677,000 | $2.0M | $4.9M | $2.8M |
| Income tax | $1.8M | $1.6M | -$2.2M | $133,000 | -$6.1M | $0 | $0 | $0 | $0 | $0 |
| Net income | $66.4M | $24.1M | -$74.4M | -$36.6M | -$75.6M | -$34.9M | -$12.6M | -$23.0M | — | — |
| EPS (diluted) | $0.82 | $0.31 | $-1.02 | $-0.51 | $-1.11 | $-0.66 | $-0.27 | — | — | — |
| Operating cash flow | $136.3M | $75.1M | $44.2M | $7.5M | -$31.6M | -$9.7M | -$3.2M | -$13.5M | -$23.9M | -$28.0M |
| Free cash flow | $126.6M | $63.8M | $34.3M | -$1.0M | -$37.0M | -$12.5M | -$6.0M | -$15.4M | -$25.7M | -$32.2M |
| Cash & equivalents | $362.6M | $239.1M | $216.5M | $154.2M | $173.2M | $349.4M | $159.3M | $78.0M | $33.9M | $59.2M |
| Inventory | $20.5M | $21.8M | $16.1M | $14.3M | $11.2M | $4.7M | $6.8M | $3.4M | $5.3M | $3.5M |
| Total assets | $1.4B | $1.3B | $1.1B | $1.2B | $1.2B | $457.2M | $275.2M | $120.6M | $78.7M | $101.0M |
| Total liabilities | $96.4M | $124.1M | $70.8M | $81.2M | $91.3M | $35.9M | $35.8M | $40.9M | $41.4M | $41.5M |
| Shareholders' equity | $1.3B | $1.2B | $1.0B | $1.1B | $1.1B | $421.2M | $239.5M | $79.8M | $37.2M | $59.6M |
Growth · year-over-year · Revenue CAGR 25.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +16.0% | +23.5% | +21.8% | +35.1% | +86.8% | -2.4% | +30.8% | +27.9% | +10.6% | +31.5% |
| Net income growth | +174.9% | — | — | — | — | — | — | — | — | — |
| EPS growth | +164.5% | — | — | — | — | — | — | — | — | — |
| Free cash flow growth | +98.5% | +86.2% | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.